BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/13/2025 1:39:41 PM | Browse: 173 | Download: 615
 |
Received |
|
2025-04-02 02:39 |
|
Peer-Review Started |
|
2025-04-02 02:40 |
|
First Decision by Editorial Office Director |
|
2025-04-09 11:58 |
|
Return for Revision |
|
2025-04-09 11:58 |
|
Revised |
|
2025-04-17 05:39 |
|
Publication Fee Transferred |
|
2025-04-19 04:15 |
|
Second Decision by Editor |
|
2025-05-13 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-05-13 06:58 |
|
Articles in Press |
|
2025-05-13 06:58 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-21 09:49 |
|
Publish the Manuscript Online |
|
2025-06-13 13:39 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhi-Yuan Yao, Jie Liu, Xiao Ma, Wan-Ting Li, Yu Shen, Yong-Zheng Cui, Yan Fang, Zheng-Xiang Han and Chun-Hua Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chun-Hua Yang, MD, PhD, Professor, Department of Radiotherapy, The Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Xuzhou 221000, Jiangsu Province, China. 13063518075@126.com |
| Key Words |
Gastric cancer; HER2-negative gastric cancer; Programmed death-1 inhibitor; Predictive model; Efficacy; Safety |
| Core Tip |
This study is the first to validate the prognostic value of the fibrinogen-to-albumin ratio (FAR) in advanced HER2-negative gastric cancer patients receiving immunochemotherapy. High FAR was significantly associated with shorter progression-free survival and overall survival, establishing FAR as an independent prognostic factor. The predictive model incorporating FAR allows for personalized survival predictions, offering a valuable and cost-effective tool for clinical decision-making. These findings underscore FAR's potential as a practical biomarker for guiding treatment strategies in advanced gastric cancer. |
| Publish Date |
2025-06-13 13:39 |
| Citation |
Yao ZY, Liu J, Ma X, Li WT, Shen Y, Cui YZ, Fang Y, Han ZX, Yang CH. Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy. World J Gastrointest Oncol 2025; 17(6): 107980 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i6/107980.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i6.107980 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
